22/02/2020
Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings
Yoshiki Kusama, Masahiro Ishikane, Chika Tanaka, Yuki Kimura, Daisuke Yamasaki, Masaki Tanabe, Yuichi Muraki, Norio Ohmagari
JAC-Antimicrobial Resistance, Volume 2, Issue 1, March 2020, dlaa004,
our study revealed that aminoglycosides were the most frequently prescribed PABs in outpatient settings, especially in children, in Japan. It was hypothesized that aminoglycosides were used as inhalational therapy. Thus, aminoglycoside inhalational therapy may be a pitfall of ASPs in outpatient settings and further studies evaluating the reasons behind aminoglycoside use in outpatient settings are needed.
Sir,